Cullgen Inc. Alternatives & Competitors
12 companies similar to Cullgen Inc. — Powering protein degradation for tomorrow's medicines
Companies similar to Cullgen Inc.
Avilar Therapeutics
Pioneering the discovery and development of extracellular protein degraders.
Waltham, United States
Arvinas
Leading the way in targeted protein degradation therapeutics
New Haven, United States
-Ltd.-logo. "CV6 Therapeutics, (NI) Ltd."){kind=logo}
CV6 Therapeutics, (NI) Ltd.
CV6 Therapeutics is dedicated to improving patients lives through the development of novel...
United Kingdom
Adcentrx Therapeutics
Merging Chemistry and Biology to Benefit the Lives of Patients
San Diego, United States
Track all Cullgen Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Captor Therapeutics SA
Captor Therapeutics aims to treat cancer, infections, and diseases by targeting the diffic...
Poland
Differentiated Therapeutics Inc
What if you could predict molecules to make the cause of disease disappear?
San Diego, United States
FogPharma
Until everything is druggable.
Cambridge, United States
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
Waltham, United States
Redx Pharma
Biotech company focusing on the discovery and development of novel targeted medicines to t...
United Kingdom
DEM Biopharma, Inc.
Novel Target for Solid Tumors
Cambridge, United States
Frontier Medicines
Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transfor...
South San Francisco, Unit...
Xanthus Pharmaceuticals
Innovative treatments for cancer and autoimmune disorders through pioneering small-molecul...
About Cullgen Inc.
Cullgen Inc., founded in 2018, is at the forefront of the biopharmaceutical sector with its pioneering slogan: "Powering protein degradation for tomorrow's medicines." The company is headquartered in the United States and operates in the Biotechnology and Pharmaceutical industries. Leveraging its proprietary uSMITE™ te...
Development of protein degraders, Research in novel E3 ligands, Non-opioid pain treatment solutions, Biopharmaceutical pipeline development
Pharmaceutical industry, Biotech researchers, Healthcare providers, Patients with debilitating diseases
Biopharmaceutical, Protein Degradation Technology, USMITE™, E3 Ligands, Drug Discovery, Cancer Treatment, Inflammatory Diseases, Autoimmune Diseases, Undruggable Targets, Therapeutic Approaches, Intracellular Disease Targets, Novel Treatment, Protein Disposal System, Small Molecule Therapies, Disease-causing Proteins
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Cullgen Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Cullgen Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 26 Jul 2024 and 20 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
